Growth Metrics

Standard Biotools (LAB) Cash from Operations Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 Standard Biotools 448.37 Mn -6.80 Mn 11.31 Mn -53.87%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -53.87%
Dec 31, 2025 91.54%
Sep 30, 2025 20.33%
Jun 30, 2025 47.07%
Mar 31, 2025 51.53%
Dec 31, 2024 0.01%
Sep 30, 2024 -144.21%
Jun 30, 2024 -318.59%
Mar 31, 2024 -636.31%
Dec 31, 2023 26.69%
Sep 30, 2023 53.63%
Jun 30, 2023 68.89%
Mar 31, 2023 45.57%
Sep 30, 2022 33.59%
Jun 30, 2022 -8.79%
Mar 31, 2022 -20.84%
Sep 30, 2021 -705.81%
Jun 30, 2021 -887.99%
Mar 31, 2021 -200.37%
Dec 31, 2020 32.36%
Sep 30, 2020 -1.12%
Jun 30, 2020 44.34%
Mar 31, 2020 78.66%
Dec 31, 2019 -765.05%
Sep 30, 2019 -11.91%
Jun 30, 2019 -15.96%
Mar 31, 2019 -24.44%
Dec 31, 2018 -196.52%
Sep 30, 2018 49.08%
Jun 30, 2018 47.85%
Mar 31, 2018 -90.57%
Dec 31, 2017 106.16%
Sep 30, 2017 39.82%
Jun 30, 2017 -12.73%
Mar 31, 2017 -8.93%
Dec 31, 2016 -143.64%
Sep 30, 2016 -4.43%
Jun 30, 2016 6.07%
Mar 31, 2016 20.49%
Dec 31, 2015 -24.94%
Sep 30, 2015 -43.29%
Jun 30, 2015 -2,609.29%
Mar 31, 2015 7.08%
Dec 31, 2014 -208.86%
Sep 30, 2014 -577.60%
Jun 30, 2014 111.83%
Mar 31, 2014 -1,093.10%
Dec 31, 2013 192.54%
Sep 30, 2013 60.79%
Jun 30, 2013 34.08%
Mar 31, 2013 86.69%
Dec 31, 2012 -55.17%
Sep 30, 2012 -40.23%
Jun 30, 2012 65.75%
Mar 31, 2012 -440.52%
Dec 31, 2011 0.27%
Sep 30, 2011 26.12%